Advertisement
Screener

LIFEVANTAGE CORP (LFVN) Form D

LIFEVANTAGE CORP Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2010-02-10: Federal exemption Rule 506; Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2009-11-18; Total offering amount $5,000,000.
  • 2009-07-13: Federal exemption Rule 506; 46; Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2009-06-30; Total offering amount $1,500,000.
  • 2009-04-16: Federal exemption Rule 506; 46; Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2009-03-10; Total offering amount $3,500,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2010-02-10Rule 506Debt; OptionToAcquire; SecurityToBeAcquired2009-11-18$5,000,000$2,634,143$2,365,85756
2009-07-13Rule 506; 46Equity; OptionToAcquire; SecurityToBeAcquired2009-06-30$1,500,000$1,500,000$034
2009-04-16Rule 506; 46Equity; OptionToAcquire; SecurityToBeAcquired2009-03-10$3,500,000$3,500,000$093

Similar stocks

Stock NameCountryMarket CapPE Ratio
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41